Comments
Commented by André Will-Laudien on October 4th, 2024 | 07:00 CEST
Top stocks performance check: Plug Power, Nel ASA, Altech Advanced Materials, VW, and BYD
A fierce battle has broken out in the automotive market. Habeck is considering reinstating the 2023 environmental subsidies due to a sharp drop in electric vehicle sales, but important market shares have already been lost. In the area of energy transition, Germany is progressing slowly, while nuclear energy is experiencing a global renaissance. Fortunately, innovative concepts are repeatedly emerging from small and medium-sized companies that are helping advance Germany as a business location. While hydrogen continues to play a peripheral role, Altech Advanced Materials has now launched the first prototype of a sodium chloride solid-state battery. For dynamic investors, this presents an explosive environment with extraordinary return opportunities.
ReadCommented by Fabian Lorenz on October 3rd, 2024 | 14:05 CEST
100% with HelloFresh! Are Bayer and dynaCERT taking off next?
Since the low in June, the HelloFresh share has roughly doubled. Not bad for an MDAX-listed stock with a market capitalization of EUR 1.6 billion. Can it continue at this pace, or would it be better to take profits? Analysts weigh in with their assessment. dynaCERT shows great potential. With a new German CEO, the Canadian company aims to make diesel engines more efficient and low-emission in Europe. And what is Bayer doing? Will the positive news flow help it to break out of the consolidation?
ReadCommented by Juliane Zielonka on October 3rd, 2024 | 14:00 CEST
Vidac Pharma, BioNTech, Gerresheimer optimize the value chain - From research to patient
Medical innovation and rapid therapy development are gaining momentum thanks to the use of AI. In this context, companies in the pharmaceutical and biotech industry are relying on groundbreaking technologies and strategies to optimize the value chain from research to patient. Vidac Pharma is researching an innovative approach to fighting cancer by supporting the body's own immune defenses. The Company has now received a patent in the US, granting exclusivity. BioNTech is using AI-powered research to bring innovative therapies to patients more quickly. Gerresheimer is producing advanced packaging solutions for pharmaceuticals that have the potential to improve healthcare significantly. We take a look at current annual reports and value chains.
ReadCommented by Juliane Zielonka on October 2nd, 2024 | 07:45 CEST
Desert Gold, Barrick Gold, Alibaba – Gold Rush Fever in Africa and Asia
The US Federal Reserve recently cut interest rates, with further cuts expected. Lower interest rates make gold more attractive as an interest-free investment. Demand for gold is increasing among both institutional and private investors. Desert Gold Ventures is taking advantage of the current gold boom and is expected to start producing the precious metal in West Africa in the second half of 2025. A prominent neighbour in the West African region is Barrick Gold. The Company is forecasting growth of around 30% in the coming years. Online giant Alibaba, on the other hand, is taking advantage of the latest economic stimuli in China to expand its leadership in the e-commerce sector further. These trends are also catching the eye of prominent investors.
ReadCommented by Fabian Lorenz on October 2nd, 2024 | 07:30 CEST
50% upside potential and more! TUI, BASF, Saturn Oil + Gas
Is BASF a buy after the strategy change? Yes, say the analysts at DZ Bank. The dividend cut is considered the right move, and the stock has around 20% upside potential. Analysts see more than 50% upside potential at Saturn Oil & Gas. The Company was recently named the fastest-growing oil company in Canada for the second time. It is rare to see such a growth champion also praised as a value play, making the stock worth a closer look. And what about TUI? The stock is struggling with the EUR 7 mark, but Deutsche Bank sees upside potential.
ReadCommented by Armin Schulz on October 2nd, 2024 | 07:00 CEST
Evotec, Nyxoah, Carl Zeiss Meditec – Biotech and medtech stocks with potential
The biotechnology and medical technology industries are driving medical innovation and offering exciting investment opportunities. Evotec, Nyxoah, and Carl Zeiss Meditec stand out among the companies that are particularly prominent in these areas. Evotec has established itself through its collaborative strategy in drug discovery and is using modern technologies such as AI to accelerate the discovery process. The emerging medtech company Nyxoah is focusing on innovative solutions for the treatment of sleep apnea. Carl Zeiss Meditec is a leader in ophthalmology and microsurgery with world-class optical devices and advanced visualization technologies. All three companies have recently seen their stock prices come under pressure and now offer an entry opportunity.
ReadCommented by Armin Schulz on October 1st, 2024 | 07:30 CEST
BP, Globex Mining, Palantir – Energy, raw materials, and data are economic drivers
In today's global economy, energy, raw materials, and data are among the most essential goods, forming the backbone of our industries and services. Energy drives the production machines and digital infrastructure, while raw materials provide the critical building blocks for almost all physical products. At the same time, data is becoming increasingly strategic due to digitalization and increasing connectivity, providing valuable insights and decision-making tools. Therefore, the security, efficient use, and sustainable management of these resources are crucial for economic growth and technological progress in an increasingly interconnected world.
ReadCommented by André Will-Laudien on October 1st, 2024 | 07:15 CEST
New DAX highs – are 100% gains still possible for Airbus, Rheinmetall, Almonty, or Hensoldt after the correction?
With a new all-time high of over 19,400 points, the DAX has now run very far. The drivers are the recent interest rate cuts by the central banks and hopes of an early change of government in Berlin. Despite the widespread euphoria, some top stocks have already corrected significantly. Possible peace negotiations in Ukraine initially pushed down the well-performing armaments stocks. However, with the renewed escalation of Russian attacks, these hopes have once again faded into the distance. As a result, defense stocks and tungsten supplier Almonty Industries are back in the spotlight. Strategic metals also remain on the shopping lists of Western nations, and the focus is now on securing the supply chains as best as possible. Where are the opportunities for investors?
ReadCommented by Stefan Feulner on October 1st, 2024 | 07:00 CEST
Mutares, 123fahrschule, Porsche SE – Incisive news
After the attack by US short seller Gotham City, the holding company Mutares is struggling to regain its footing while the battered share price continues to search in vain for a bottom. Less surprising, given that the crisis in the German automotive industry has already been discussed at length in the press of late, was Volkswagen's sales and profit warning. In contrast, decisions could be made within about two weeks that may reshape a billion-dollar market, potentially benefiting a disruptive technology company disproportionately.
ReadCommented by Stefan Feulner on September 27th, 2024 | 07:20 CEST
Almonty Industries, PowerCell Sweden, Nordex – It is all happening in quick succession
The FED's interest rate cut and announcements of further easing of monetary policy are giving the indices additional momentum. The German-leading index DAX, the Dow Jones, and the S&P 500 continue to jump from high to high. In contrast, companies in the hydrogen fuel cell sector are more than 90% away from their historical record highs. However, several companies are currently forming a sustainable bottom that could lead to a sharp rebound.
Read